He Min, Peng Anping, Huang Xian-Zhang, Shi Dai-Chao, Wang Jun-Cheng, Zhao Qiyi, Lin Haibiao, Kuang Dong-Ming, Ke Pei-Feng, Lao Xiang-Ming
Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine , Guangzhou, P.R. China.
State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center , Guangzhou, P.R. China.
Oncoimmunology. 2016 Sep 27;5(10):e1219828. doi: 10.1080/2162402X.2016.1219828. eCollection 2016.
Inflammation is a component of tumor progression mechanisms. Neutrophils are a common inflammatory infiltrate in many tumors, but their regulation and functions in neoplasia are not understood. Here, we showed, in detailed studies of c-Met molecule in 225 untreated patients with hepatocellular carcinoma (HCC), that high infiltration of neutrophils in HCC tissues determined malignant cell c-Met-associated clinical outcome of patients. High infiltration of neutrophils in HCCs determined malignant cell c-Met-associated clinical outcome of patients. Neutrophils were enriched predominantly in invading tumor edge of HCCs; the accumulated neutrophils were the major source of c-Met ligand HGF in HCCs. Exposure to HCC environments resulted in neutrophil activation and the following HGF production. Inhibiting the activities of Erk1/2, p38, and NF-κB, but not the phosphorylation of AKT or JNK, successfully attenuated the neutrophil HGF production induced by HCC environments. Further investigation revealed that GM-CSF was an important determinant in malignant cell-elicited neutrophil HGF production and . Moreover, we demonstrated that tumor neutrophils, via HGF/c-Met interaction, actively enhanced the metastasis of malignant cells and . These data provide direct evidence supporting the critical role of neutrophils in human tumor progression and reveal a fine-tuned collaborative action between cancer cells and immune cells in tumor milieu, which reroutes the immune activation into a tumor-promoting direction.
炎症是肿瘤进展机制的一个组成部分。中性粒细胞是许多肿瘤中常见的炎性浸润细胞,但它们在肿瘤形成中的调节和功能尚不清楚。在此,我们通过对225例未经治疗的肝细胞癌(HCC)患者的c-Met分子进行详细研究发现,HCC组织中中性粒细胞的高浸润决定了患者恶性细胞c-Met相关的临床结局。HCC中中性粒细胞的高浸润决定了患者恶性细胞c-Met相关的临床结局。中性粒细胞主要富集于HCC侵袭性肿瘤边缘;积聚的中性粒细胞是HCC中c-Met配体HGF的主要来源。暴露于HCC环境会导致中性粒细胞活化并随后产生HGF。抑制Erk1/2、p38和NF-κB的活性,但不抑制AKT或JNK的磷酸化,成功减弱了HCC环境诱导的中性粒细胞HGF产生。进一步研究表明,GM-CSF是恶性细胞诱导中性粒细胞产生HGF的重要决定因素。此外,我们证明肿瘤中性粒细胞通过HGF/c-Met相互作用,积极促进恶性细胞的转移。这些数据提供了直接证据,支持中性粒细胞在人类肿瘤进展中的关键作用,并揭示了肿瘤微环境中癌细胞与免疫细胞之间的精细协作作用,这种作用将免疫激活重新导向促进肿瘤的方向。